- Home
- THTX vs DERM Comparison
THTX vs DERM Comparison
Compare THTX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- DERM
- Stock Information
- Founded
- THTX 1993
- DERM 2014
- Country
- THTX Canada
- DERM United States
- Employees
- THTX N/A
- DERM N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- DERM Health Care
- Exchange
- THTX Nasdaq
- DERM Nasdaq
- Market Cap
- THTX 144.8M
- DERM 165.6M
- IPO Year
- THTX N/A
- DERM 2021
- Fundamental
- Price
- THTX $3.20
- DERM $7.57
- Analyst Decision
- THTX Hold
- DERM Strong Buy
- Analyst Count
- THTX 1
- DERM 2
- Target Price
- THTX N/A
- DERM $10.50
- AVG Volume (30 Days)
- THTX 260.8K
- DERM 112.6K
- Earning Date
- THTX 07-09-2025
- DERM 08-12-2025
- Dividend Yield
- THTX N/A
- DERM N/A
- EPS Growth
- THTX N/A
- DERM N/A
- EPS
- THTX N/A
- DERM N/A
- Revenue
- THTX $84,378,000.00
- DERM $56,243,000.00
- Revenue This Year
- THTX N/A
- DERM $28.99
- Revenue Next Year
- THTX $13.76
- DERM $52.61
- P/E Ratio
- THTX N/A
- DERM N/A
- Revenue Growth
- THTX 2.19
- DERM N/A
- 52 Week Low
- THTX $1.12
- DERM $3.54
- 52 Week High
- THTX $3.22
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- THTX 71.13
- DERM 57.73
- Support Level
- THTX $2.28
- DERM $6.90
- Resistance Level
- THTX $3.22
- DERM $8.09
- Average True Range (ATR)
- THTX 0.02
- DERM 0.38
- MACD
- THTX -0.02
- DERM -0.01
- Stochastic Oscillator
- THTX 68.75
- DERM 56.40
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.